Orange, NY, United States of America

Gary A Maier

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: American Cyanamid Company. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary A Maier. Retrieved from https://idiyas.com/inventor/gary-a-maier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gary A. Maier

Introduction

Gary A. Maier is an accomplished inventor based in Orange, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. His innovative work has led to the development of a unique patent that enhances the efficacy of medication.

Latest Patents

Gary A. Maier holds a patent for a "Sustained release delivery system for substituted dihydropyridine." This patent involves a complex of 1,4-dihydropyridine with polyoxyethylene-polyoxypropylene copolymer, which is useful in sustained release dosage formulations. This invention aims to improve the delivery and effectiveness of certain medications.

Career Highlights

Maier is associated with the American Cyanamid Company, where he has been instrumental in advancing pharmaceutical technologies. His work has not only contributed to the company's success but has also had a lasting impact on the industry.

Collaborations

Throughout his career, Gary has collaborated with notable colleagues, including Prakash S. Kulkarni and Narendra Raghunathji Desai. These partnerships have fostered innovation and have led to the successful development of various projects.

Conclusion

In summary, Gary A. Maier is a notable inventor whose work in sustained release delivery systems has made a significant impact in the pharmaceutical field. His contributions continue to influence the way medications are formulated and delivered.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…